drugset / Trial / NCT03114020
Efficacy/Safety of HA Inhalation Solution for Hereditary Emphysema in Patients With Alpha-1 Antitrypsin Deficiency
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the study is to evaluate the safety and efficacy of administering repeated doses of Hyaluronic Acid Inhalation Solution to subjects with Emphysema that have Alpha-1-Antitrypsin deficiency
Timeline
- Start
- 2017-03-22
- Primary completion
- 2019-11-12
- Completion
- 2019-11-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hyaluronic Acid | Other / unclassified | 0.03 % | Inhaled |
| Subject | Hyaluronic Acid | Other / unclassified | 3 ml | Inhaled |